Dr MARCO PRÜMMER SRL
The score of Dr MARCO PRÜMMER shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +293 % Total assets +148 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr MARCO PRÜMMER's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 91,038 € | ||||
| Equity | 262,057 € | ||||
| Cash | 21,590 € | ||||
| EBITDA | 124,649 € | ||||
| Total assets | 315,625 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 18 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Dr MARCO PRÜMMER's financial analysis
- Solvency83.0%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr MARCO PRÜMMER
Dr MARCO PRÜMMER's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.676.230
- VAT number
- BE0765676230
- Peppol
- Registered · 0208:0765676230 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Mar 2021
- Registered office
- 4730 Raeren
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- General medical practice activities (NACE 86210)
Dr MARCO PRÜMMER (SRL) has been based in Raeren since 2021, active in: general medical practice activities. For 2025, it reports a net profit of 91,038 € and equity of 262,057 €; its revenue is not published. Its solvency stands at 83.0%, above the median of its sector (65.8%).
Companies similar to Dr MARCO PRÜMMER
Companies in the same business, of comparable size and area, outside its group.
- Cabinet medical Crosset General medical practice activities Dison · balance sheet 345,056 €
- Docteur BEN JABALLAH General medical practice activities Verviers · balance sheet 370,310 €
- Dokter Van Vaerenbergh Rika General medical practice activities Denderleeuw · balance sheet 325,877 €
- Acupunctuurpraktijk Tom Verhaeghe General medical practice activities Ingelmunster · balance sheet 470,696 €
- Segers Dimitri Osteopathie General medical practice activities Lanaken · balance sheet 128,630 €
- Dr. Ariens Bruno General medical practice activities Nijlen · balance sheet 243,890 €
- HAP AW General medical practice activities Roeselare · balance sheet 316,482 €
- Huisartspraktijk Sophie Rouzeré General medical practice activities Waregem · balance sheet 319,852 €
Frequently asked questions about Dr MARCO PRÜMMER
What is the revenue of Dr MARCO PRÜMMER?
Dr MARCO PRÜMMER files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr MARCO PRÜMMER?
In Belgium, the VAT number is the company number prefixed with BE: BE0765676230 for Dr MARCO PRÜMMER, if the company is VAT-registered. Its company number (CBE) is 0765.676.230.
Where is the registered office of Dr MARCO PRÜMMER?
According to the CBE register, the registered office of Dr MARCO PRÜMMER is in 4730 Raeren.
What is the equity of Dr MARCO PRÜMMER?
At the close of the 2025 financial year, the equity of Dr MARCO PRÜMMER amounts to 262,057 €, a solvency of 83.0% of total assets.
Who manages Dr MARCO PRÜMMER?
The register lists 1 active mandates at Dr MARCO PRÜMMER. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr MARCO PRÜMMER
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →